Appropriate cut-off value for follicle-stimulating hormone in azoospermia to predict spermatogenesis
Open Access
- 8 September 2010
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 108
Abstract
Background: This study was undertaken to determine the optimal cut-off value for FSH to predict the presence of spermatogenesis in patients with non-obstructive azoospermia. Methods: A total of 206 non-obstructive azoospermic men were enrolled in this prospective study. By using receiver operating characteristic (ROC) curves, we determined the optimal cut-off value for FSH and evaluated whether the test could adequately predict successful sperm retrieval. Results: There were 108 non-obstructive azoospermic patients who had evidence of spermatogenesis (group A) and achieved success in sperm retrieval. Another 98 non-obstructive azoospermic patients (group B) failed in sperm retrieval. The mean value of serum FSH in group B was significantly higher than in group A (28.03 +/- 14.56 mIU/mL vs 7.94 +/- 4.95 mIU/mL, p < 0.01; respectively). The area under the receiver operating characteristic curves were 0.939 +/- 0.02 and a cut-off value of 19.4 mIU/mL discriminated between group A and B with a sensitivity of 70%. The positive predictive value for failed sperm retrieval (group B) can reach 100%. Conclusions: Elevated plasma levels of FSH of more than 19.4 mIU/mL could be used as a reliable criterion for a trial of sperm retrieval from testes in artificial reproductive techniques.Keywords
This publication has 25 references indexed in Scilit:
- Sperm Retrieval Rates in Subgroups of Primary Azoospermic MalesEuropean Urology, 2007
- Predicting sperm retrieval rates in testicular sperm extraction for azoospermia according to endocrine profilesReproductive Medicine and Biology, 2005
- Seminal plasma inhibin‐B level is a useful predictor of the success of conventional testicular sperm extraction in patients with non‐obstructive azoospermiaJournal of Obstetrics and Gynaecology Research, 2005
- Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue SamplesThe Journal of Clinical Endocrinology & Metabolism, 1999
- Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish MenThe Journal of Clinical Endocrinology & Metabolism, 1997
- Testis Biopsies Frequently Demonstrate Sperm in Men With Azoospermia and Significantly Elevated Follicle-Stimulating Hormone LevelsJournal of Urology, 1997
- Testicular Touch Preparation CytologyJournal of Urology, 1996
- Serum FSH and testicular morphology in male infertilityClinical Endocrinology, 1994
- Indications for Testicular Biopsy or Exploration in AzoospermiaBritish Journal of Urology, 1978
- Can Follicle Stimulating Hormone Estimation Replace Testicular Biopsy in the Diagnosis of Obstructive Azoospermia?British Journal of Urology, 1978